Clinical Rheumatology

, Volume 31, Issue 10, pp 1455–1461 | Cite as

Quantitative assessment of the “inexplicability” of fibromyalgia patients: a pilot study of the fibromyalgia narrative of “medically unexplained” pain

Original Article


The purpose of this study was to quantify the degree to which fibromyalgia patients perceive the cause of their pain to be inexplicable or difficult to understand. The author developed two simple Likert scales, Understand Pain Scale and Explain Pain Scale, which ask the subject to indicate the degree to which they are able to, respectively, understand the cause of their pain and to explain the cause of their pain to others. A total of 104 subjects who met the 1990 American College of Rheumatology Diagnostic Criteria for fibromyalgia (FM group), and 272 subjects with widespread pain who did not meet these criteria (non-FM group) completed these two instruments. On the Understand Pain Scale, 67.3 % of FM subjects endorsed either the item “understand very little about the cause of my pain (the reason I have pain)” or “cannot understand at all the cause of my pain (the reason I have pain)”. By comparison, 16.2 % of the non-FM group with widespread pain endorsed either of these Understand Pain Scale items. On the Explain Scale, 84.6 % of fibromyalgia subjects endorsed either the item “can very little or not very often explain the cause of my pain (the reason I have pain) to others” or “cannot at all explain the cause of my pain (the reason I have pain) to others”. In contrast, 21.7 % of non-FM group subjects with widespread pain endorsed either of the aforementioned items. Compared to other patients with chronic, widespread pain, fibromyalgia patients report a much greater degree of difficulty in understanding the cause of their pain and explaining the cause of their pain to others. This phenomenon may reflect the narrative of “inexplicability” in fibromyalgia patients that distinguishes them from other widespread pain populations.


Back pain Chronic pain Fibromyalgia Widespread pain 





  1. 1.
    Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62:600–610CrossRefGoogle Scholar
  2. 2.
    Wolfe F (2010) New American College of Rheumatology Criteria for fibromyalgia: a twenty-year journey. Arthritis Care Res 62(5):583–584CrossRefGoogle Scholar
  3. 3.
    Glattacker M, Opitz U, Jäckel WH (2010) Illness representations in women with fibromyalgia. Br J Health Psych 15:367–387CrossRefGoogle Scholar
  4. 4.
    McMahon L, Murray C, Simpson J. The potential benefits of applying a narrative analytic approach for understanding the experience of fibromyalgia: a review. Disabil Rehabil 2011;1-10, early online.Google Scholar
  5. 5.
    Bennett RM (1996) Fibromyalgia and the disability dilemma. Arthritis Rheum 39:1627–1634PubMedCrossRefGoogle Scholar
  6. 6.
    Russell IJ (2011) Future perspectives in generalised musculoskeletal pain syndromes. Best Pract Res Clin Rheumatol 25:321–331PubMedCrossRefGoogle Scholar
  7. 7.
    Sarzi-Puttini P, Atzeni F, Salaffi F, Cazzola M, Benucci M, Mease PJ (2011) Multidisciplinary approach to fibromyalgia: what is the teaching? Best Pract Res Clin Rheumatol 25:311–319PubMedCrossRefGoogle Scholar
  8. 8.
    Mease PJ, Dundon K, Sarzi-Puttini P (2011) Pharmacotherapy of fibromyalgia. Best Pract Res Clin Rheumatol 25:285–297PubMedCrossRefGoogle Scholar
  9. 9.
    Gracely RH, Ambrose KR (2011) Neuroimaging of fibromyalgia. Best Pract Res Clin Rheumatol 25:271–284PubMedCrossRefGoogle Scholar
  10. 10.
    Casale R, Rainoldi A (2011) Fatigue and fibromyalgia syndrome: clinical and neurophysiologic pattern. Best Pract Res Clin Rheumatol 25(2):241–247PubMedCrossRefGoogle Scholar
  11. 11.
    Spaeth M, Rizzi M, Sarzi-Puttini P (2011) Fibromyalgia and sleep. Best Pract Res Clin Rheumatol 25(2):227–239PubMedCrossRefGoogle Scholar
  12. 12.
    Atzeni F, Cazzola M, Benucci M, Di Franco M, Salaffi F, Sarzi-Puttini P (2011) Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol 25(2):165–171PubMedCrossRefGoogle Scholar
  13. 13.
    Staud R (2011) Peripheral pain mechanisms in chronic widespread pain. Best Pract Res Clin Rheumatol 25(2):155–164PubMedCrossRefGoogle Scholar
  14. 14.
    Phillips K, Clauw DJ (2011) Central pain mechanisms in chronic pain states—maybe it is all in their head. Best Pract Res Clin Rheumatol 25(2):141–154PubMedCrossRefGoogle Scholar
  15. 15.
    Stone J, Wojcik W, Durrance D, Carson A, Lewis S et al (2002) What should we say to patients with symptoms unexplained by disease? The “number needed to offend”. BMJ 325:1449–1450PubMedCrossRefGoogle Scholar
  16. 16.
    Wentz KA, Lindberg C, Hallberg LR (2004) Psychological functioning in women with fibromyalgia: a grounded theory study. Health Care Women Int 25:702–729PubMedCrossRefGoogle Scholar
  17. 17.
    Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ et al (1997) Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 40:1571–1579PubMedCrossRefGoogle Scholar
  18. 18.
    Friedberg F (2010) Chronic fatigue syndrome, fibromyalgia, and related illnesses: a clinical model of assessment and intervention. J Clin Psychol 66:641–665PubMedGoogle Scholar
  19. 19.
    Hellström O, Bullington J, Karlsson G, Lindqvist P, Mattsson BA (1999) phenomenological study of fibromyalgia. Patient perspectives. Scand J Prim Health Care 17:11–16PubMedCrossRefGoogle Scholar
  20. 20.
    Sim J, Madden S (2008) Illness experience in fibromyalgia syndrome: a metasynthesis of qualitative studies. Soc Sci Med 67:57–67PubMedCrossRefGoogle Scholar
  21. 21.
    Madden S, Sim J (2006) Creating meaning in fibromyalgia syndrome. Soc Sci Med 63:2962–2973PubMedCrossRefGoogle Scholar
  22. 22.
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C et al (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRefGoogle Scholar
  23. 23.
    Spitzer WO, Skovron ML, Salmi LR et al (1995) Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management. Spine 20(8 Suppl):1S–73SPubMedGoogle Scholar
  24. 24.
    Nijs J, van Wilgen C, Van Oosterwijck J, van Ittersum M, Meeus M (2011) How to explain central sensitization to patients with 'unexplained' chronic musculoskeletal pain: practice guidelines. Man Ther 16:413–418PubMedCrossRefGoogle Scholar
  25. 25.
    van Ittersum MW, van Wilgen CP, Hilberdink WKHA, Groothoff JW, van de Schans CP (2009) Illness perceptions in patients with fibromyalgia. Patient Education 74:53–60CrossRefGoogle Scholar
  26. 26.
    Ferrari R, Russell AS, Carroll LJ, Cassidy JD (2005) A re-examination of the whiplash-associated disorders (WAD) as a systemic illness. Ann Rheum Dis 64:1337–1342PubMedCrossRefGoogle Scholar
  27. 27.
    Carroll LJ, Rothe JP (2010) Levels of reconstruction as complementarity in mixed methods research: a social theory-based conceptual framework for integrating qualitative and quantitative research. Int J Environ Res Public Health 7:3478–3488PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2012

Authors and Affiliations

  1. 1.Department of MedicineUniversity of AlbertaEdmontonCanada

Personalised recommendations